
News
Advertisement


Advertisement

With issues surrounding COVID-19, the cornoavirus, grabbing headlines across the country and around the globe, ophthalmologists must understand the risks to be informed and positioned to provide quality care for their patients.



Advertisement













Delivering the Drs. Henry and Frederick Sutro Memorial Lecture, David W. Parke II, MD, CEO of the American Academy of Ophthalmology, points out that patients and physicians can benefit from innovations in treatment. However, health policy and economics often can stand in the way of innovation.




The Glaucoma Symposium offers ophthalmology and optometry professionals an opportunity to sharpen their knowledge about glaucoma.






Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
2
Recognizing biomarkers of Alzheimer Disease using OCTA
3
Midyear cataract check-in: What 2026 has brought to the OR and beyond
4
Durability With Aflibercept 8 mg in Retinal Vascular Diseases
5


